NRO Neurones SA

NEURONES: Organic growth up 5.3% in 2nd quarter 2025

NEURONES: Organic growth up 5.3% in 2nd quarter 2025

PRESS INFORMATION        Nanterre, August 6, 2025 (after trading)

Heading: 1st half 2025 revenues

Organic growth up 5.3% in 2nd quarter 2025

Revenues (millions of euros)20242025Growthof which organic
Q1204.9214.1+ 4.5%+ 3.9%
Q2197.5210.2+ 6.4%+ 5.3%
Total H1 revenues402.4424.3+ 5.4%+ 4.6%

Achievements

Organic growth of 5.3% in the second quarter was achieved in a more challenging economic environment.

The most notable growth was in Data, Digital projects, market finance, ITSM (Service Now) solutions, and Business Process Management, with the use of AI both for customer projects and to boost productivity in internal processes.

The challenging environment (pressure on prices, lower utilization rates, unfavorable impact of tax and social measures) led to a 1.4% decline in margins compared to the first half of 2024, resulting in operating profit (*) of 7.8% of revenue for the half-year.

(*) not audited and after inclusion of 1% of expenses related to bonus shares.

Outlook        

NEURONES is upping its revenue forecast for the whole year to around €850 million and, with action plans in place, is adjusting its operating profit forecast to around 8%.

About NEURONES

With 7,250 experts, and ranking among the French leaders in management consulting and digital services, NEURONES helps large companies and organizations implement their digital projects, transform their IT infrastructures and adopt new uses.

Euronext Paris (compartment A - NRO) – Euronext Tech Leaders – DSS – PEA-PME eligible



Press Relations:

O'Connection

Julia Philippe-Brutin

Tel.: +33 (0)6 03 63 06 03









NEURONES

Matthieu Vautier

Tel.: +33 (0)1 41 37 41 37



Investor Relations:

NEURONES

Paul-César Bonnel

Tel.: +33 (0)1 41 37 41 37



Attachment



EN
06/08/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Neurones SA

 PRESS RELEASE

NEURONES: 5.1% organic growth in 2025

NEURONES: 5.1% organic growth in 2025 PRESS INFORMATIONHeading: 2025 annual revenues        Nanterre, February 11, 2026 (after trading) 5.1% organic growth in 2025 (being audited, in € millions)20242025Growthof which organic4rd quarter revenues211.3225+ 6.5%+ 6.2%Annual revenues810.4857.2+ 5.8%+ 5.1% Achievements NEURONES closes the financial year with annual revenue of €857.2 million, exceeding its expectations. Growth is driven by digital and data projects (double-digit growth), while AI-related activities confirm a promising upward trend. With its decentralized and responsive structu...

 PRESS RELEASE

NEURONES : + 5,1% de croissance organique en 2025

NEURONES : + 5,1% de croissance organique en 2025 INFORMATION PRESSERubrique : C.A. annuel 2025        Nanterre, le 11 février 2026 (après Bourse) + 5,1% de croissance organique en 2025 (en cours d’audit, en M€)20242025Croissancedont organiqueChiffre d’affaires 4e trimestre211,3225+ 6,5%+ 6,2%Chiffre d’affaires annuel810,4    857,2+ 5,8%+ 5,1% Réalisations NEURONES clôture l’exercice avec un chiffre d’affaires annuel de 857,2 M€, dépassant ainsi ses anticipations. La croissance est portée par les projets digitaux et data (progression à deux chiffres), tandis que les activités liées à l’I...

 PRESS RELEASE

NEURONES: Organic growth up 5.1% in 3rd quarter 2025

NEURONES: Organic growth up 5.1% in 3rd quarter 2025 PRESS INFORMATIONHeading: 3rd quarter 2025 revenues        Nanterre, November 5, 2025 (after trading) Organic growth up 5.1% in 3rd quarter 2025 (not audited, in millions of euros)20242025growthof which organic3rd quarter revenues196.7207.9+ 5.7%+ 5.1%Total as at the end-September599.1632.2+ 5.5%+ 4.7% Achievements In a declining French market, NEURONES has continued its momentum in the third quarter, in line with the start of the year. Growth is particularly strong in the areas of Data & AI, digital projects, ITSM (Ser...

 PRESS RELEASE

NEURONES : + 5,1% de croissance organique au 3e trimestre 2025

NEURONES : + 5,1% de croissance organique au 3e trimestre 2025 INFORMATION PRESSERubrique : C.A. 3e trimestre 2025        Nanterre, le 5 novembre 2025 (après Bourse) + 5,1% de croissance organique au 3e trimestre 2025 (non audités, en millions d’euros)20242025croissancedont organiqueChiffre d’affaires 3e trimestre196,7207,9+ 5,7%+ 5,1%Cumul à fin septembre599,1632,2+ 5,5%+ 4,7% Réalisations Dans un marché français en repli, NEURONES a poursuivi sa dynamique au 3e trimestre, dans la continuité du début de l’année. La croissance est particulièrement soutenue dans les domain...

 PRESS RELEASE

NEURONES: Declaration of transactions on treasury shares (October 13 t...

NEURONES: Declaration of transactions on treasury shares (October 13 to 17, 2025) Nanterre, October 21, 2025 Declaration of transactions on treasury shares(period from 13 to 17 October 2025) As part of the share buyback program authorized by the General Meeting of June 5, 2025, NEURONES made the following purchases between October 13 and 17, 2025 (ISIN code FR0004050250): DayTotal daily volume(in number of shares)Weighted average price(unit daily)10/16/202510,000€38.0510/17/2025      489€38.10Total10,489  As of October 17, 2025, excluding the liquidity contract, NEURONES now holds 10,489 ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch